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https://doi.org/10.1016/j.stemcr.2017.12.001SUMMARYGlial cytoplasmic inclusions (GCIs), commonly observed as a-synuclein (a-syn)-positive aggregates within oligodendrocytes, are the
pathological hallmark of multiple system atrophy. The origin of a-syn in GCIs is uncertain; there is little evidence of endogenous
a-syn expression in oligodendrocyte lineage cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes (OLGs). Here,
based on in vitro analysis using primary rat cell cultures, we elucidated that preformed fibrils (PFFs) generated from recombinant human
a-syn trigger multimerization and an upsurge of endogenous a-syn in OPCs, which is attributable to insufficient autophagic proteolysis.
RNA-seq analysis of OPCs revealed that a-syn PFFs interfered with the expression of proteins associated with neuromodulation andmye-
lination. Furthermore, we detected cytoplasmic a-syn inclusions inOLGs throughdifferentiation of OPCs pre-incubatedwith PFFs. Over-
all, our findings suggest the possibility of endogenous a-syn accumulation inOPCs that contributes toGCI formation and perturbation of
neuronal/glial support in multiple system atrophy brains.INTRODUCTION
Multiple system atrophy (MSA) is an a-synucleinopathy
characterized by a relentless worsening of motor and
non-motor symptoms during a typical time frame of
6–10 years. Glial cytoplasmic inclusions (GCIs) in
oligodendrocytes (OLGs), which consist of a-synuclein
(a-syn)-positive filamentous components, are the hallmark
for a definitive neuropathological diagnosis of MSA. Given
that the emergence of GCIs occurs prior to neuronal loss, it
is likely that a primary oligodendroglial event is the root of
the disease pathology in MSA (Wenning et al., 2008).
Since a-syn is considered to be expressed almost exclu-
sively in neurons, the origin of the a-syn that composes
GCIs in oligodendrocytes has been enigmatic. Recent re-
ports have suggested the existence of endogenous a-syn
in oligodendrocyte lineage cells, emphasizing the patho-
logical importance of endogenous a-syn as the source of
the misfolded a-syn in GCIs (Djelloul et al., 2015). The fi-
brillary form of a-syn contributes to prion-like propaga-
tion of the misfolded structure and disease progression
among both in vitro and in vivo models of synucleinopa-356 Stem Cell Reports j Vol. 10 j 356–365 j February 13, 2018 j ª 2017 The
This is an open access article under the CC BY-NC-ND license (http://creativthies (Angot et al., 2010). Considering that exogenous
a-syn preformed fibrils (PFFs) seed and recruit endogenous
a-syn to form insoluble aggregates in primary neurons, it
is of great importance to determine if exogenous a-syn
PFFs induce misfolding of endogenous a-syn in primary
oligodendrocyte lineage cells (Volpicelli-Daley et al.,
2011).
Oligodendrocyte lineage cells support neuronal activity
not only by forming a myelin sheath to enable saltatory
conduction but also by modulating axonal and neuronal
homeostasis through the supply of neurotrophic factors
(Wilkins et al., 2003). Myelin-forming mature OLGs are
derived from oligodendrocyte precursor cells (OPCs).
When activated in response to brain damage, OPCs prolif-
erate and attempt to differentiate intomature OLGs. OPCs,
which are immunoreactive to NG2 chondroitin sulfate or
platelet-derived growth factor a receptor (PDGFRa), are
distributed diffusely within the central nervous system
and account for 5%–8% of all cells in adult brains (Levine
et al., 2001). Despite the importance of OPCs in brain ho-
meostasis, there are limited numbers of pathological inves-
tigations of OPCs in MSA brains.Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
Stem Cell Reports j Vol. 10 j 356–365 j February 13, 2018 357
In the present study, we provide newpathological insight
into the interaction between endogenous and exogenous
a-syn by using primary rat oligodendrocyte lineage cell cul-
tures, and we propose the possibility of OPC involvement
in the pathogenesis of MSA.RESULTS
Oligodendrocyte Precursor Cells Contain a-Syn
Aggregates in MSA Brains
We investigated whether OPCs contain a-syn aggregates
in MSA brains. One previous analysis revealed that a
small fraction of OPCs in MSA cases showed a-syn immu-
noreactivity, which was also confirmed by our postmortem
investigation (May et al., 2014) (Figure S1A). The a-syn
immunoreactivity in OPCs was stained with Thioflavin S,
suggesting that the a-syn aggregate was misfolded. These
results suggest that not only OLGs but OPCs may also
contain a-syn aggregates in MSA brains.
Oligodendrocyte Lineage Cells in Rat Primary
Cultures Express Moderate Amounts of a-Syn
To confirm the endogenous a-syn expression in oligoden-
drocyte lineage cells, primary oligodendrocyte lineage cell
cultures were obtained from neonatal rats. Consistent
with previous reports, anti-a-syn antibody immunostained
endogenous a-syn within OPCs and OLGs with cyto-
plasmic predominance (Figures S1B and S1C) (Richter-
Landsberg et al., 2000). Immunoblot analysis showed that
oligodendroglial endogenous a-syn expression at 4–6 days
after plating was slightly greater than 20% of the neuronal
a-syn expression (Figures S1D and S1E). Consistent with
immunoblot analysis, quantitative real-time PCR (qPCR)Figure 1. Internalization of Recombinant Human a-Syn PFFs Induc
(A) Confocal microscopy of OPCs and OLGs incubated with a-syn PFFs (
The magnified view of an OPC reveals intracellular a-syn immunoreacti
(B) Immunoelectron microscopy of a-syn PFF (1 mM)-treated OPCs rev
a-syn antibody (arrowheads). The antibody recognizes both rat and hu
100 nm, respectively. (b) Dotted line indicates cell surface. N, nucleu
(C) Immunoelectron microscopy of a-syn PFF (1 mM)-treated OLGs sh
are labeled with anti-a-syn antibody (arrowheads). The antibody recog
and (b) 500 nm, respectively. (b) Dotted line indicates cell surface. N
(D) Confocal microscopy with human-specific (exogenous) and rat-sp
expression of endogenous a-syn in a-syn PFF (3 mM)-treated OPCs. T
treated with a-syn PFFs (3 mM). White arrowheads indicate locati
observed. Each scale bar represents 20 mm.
(E) The magnified view of a-syn PFF (1 mM)-treated OPCs shows intrace
(white arrowheads). The bar represents 5 mm.
(F) Immunoblot analysis with a rat-specific anti-a-syn antibody revea
endogenous rat a-syn, with a remarkable increase in the total amoun
(G) Quantification of endogenous rat a-syn accumulation in a-syn PFF
total and multimer endogenous rat a-syn are significantly increased
independent cultures; one-way ANOVA, *p < 0.05.
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10%–20% of the amount of a-syn transcripts expressed
in neurons (Figure S1F). Immunoblot analysis, immunocy-
tochemistry, and qPCR analysis using each cell marker
validated the high purity of each cell-type culture (Figures
S1D and S1G–S1I, and Movies S1 and S2).Exogenous a-Syn PFFs Are Internalized into OPCs
To elucidate the impact of extracellular a-syn PFFs on
primary oligodendrocyte lineage cells, these cells were
incubated with either recombinant human a-syn PFFs or
monomer for 24 hr and immunostained with an anti-
a-syn antibody. When OPCs and OLGs were incubated
with a-syn PFFs, prominent a-syn immunoreactivity was
observedon the cellmembranes.Observationof themagni-
fied images obtained by confocal microscopy enabled visu-
alizationof internalizationofa-synpredominantly inOPCs
but not in OLGs (Figure 1A), which was also confirmed by
immunoelectron microscopy showing the intracellular
localization of a-syn fibrils in OPCs (Figures 1B and 1C).
Meanwhile, the enhanced a-syn immunoreactivity was
not found either inOPCs orOLGs exposed to an equivalent
amountofa-synmonomer (Figure S2A). Thecytosolic local-
izationof exogenous a-syn inOPCswas also verified by sub-
cellular fractionation of these cells (Figure S2B).Endogenous a-Syn Protein Expression in OPCs
Dramatically Increases in Response to Exogenous
Recombinant Human a-Syn PFFs
To visualize the interaction between exogenous human
a-syn and endogenous rat a-syn in OPCs and OLGs, cells
were immunostained with an anti-a-syn antibody that
specifically recognizes rodent a-syn (endogenous a-syning Accumulation and Multimerization of Endogenous Rat a-Syn
3 mM) shows prominent a-syn accumulation on the cell membranes.
vity, which is not observed in OLGs. Each scale bar represents 10 mm.
eals intracellular fibril-like structures, which are labeled with anti-
man a-syn. Each scale bar represents (a) 2 mm, (b) 500 nm, and (c)
s.
ows extracellularly distributed layers of fibril-like structures, which
nizes both rat and human a-syn. Each scale bar represents (a) 2 mm
, nucleus.
ecific (endogenous) anti-a-syn antibodies identifies the enhanced
he increase in rat-specific a-syn expression is less notable in OLGs
ons where endogenous rat a-syn accumulation is predominantly
llular colocalization of exogenous human and endogenous rat a-syn
ls that 24-hr incubation with a-syn PFFs induces multimerization of
t of endogenous rat a-syn in OPCs.
-treated OPCs and OLGs by immunoblot analysis is illustrated. Both
in OPCs by a-syn PFF application. Mean ± SEM; n = 5, respectively,
Figure 2. Insufficient Autophagic Degradation in OPCs Trig-
gered by a-Syn PFF Application
(A) Accumulation of Triton-insoluble endogenous rat a-syn in OPCs
is triggered by a-syn PFF (3 mM) application.
(B) Quantitative real-time PCR reveals unchanged Snca expression
levels after 72-hr incubation of oligodendrocyte lineage cells with
3 mM a-syn PFFs. Mean ± SEM; n = 6, respectively, independent
cultures; paired t test. NS, not statistically significant.antibody) (Figure S2C). In response to incubation with
exogenous a-syn PFFs, the endogenous a-syn expressions
in OPCs were remarkably enhanced (Figures 1D and
S2D). The enhanced immunoreactivity of endogenous
a-syn colocalized with that of exogenous a-syn in the cyto-
plasm of OPCs (Figures 1E and S2B). The cytoplasmic inclu-
sions immunostainedwith the endogenous a-syn antibody
were also stained with Thioflavin S, which was exclusively
observed in OPCs (Figures S2E and S2F). Immunoblot anal-
ysis revealed a drastically increased amount of endogenous
a-syn expression in OPCs characterized by the emergence
of multimerized a-syn as the result of a-syn PFF application
(Figures 1F and 1G). On the other hand, there wasminimal
change in the total amount of endogenous a-syn expres-
sion in OLGs, as shown by both immunostaining and
immunoblot analysis. Monomeric a-syn did not alter the
protein expression pattern of endogenous a-syn in OPCs
(Figure S2G). Despite the striking evidence of inclusion for-
mation in OPCs, the expression of phosphorylated a-syn
was not confirmed either in immunostaining or immuno-
blot analysis (Figures S2H and S2I).
Impairment of Autophagy Contributes to Endogenous
a-Syn Accumulation in OPCs
Incubation of OPCs with a-syn PFFs facilitated expression
of endogenous a-syn not only in Triton-soluble fractions
but also in Triton-insoluble fractions (Figure 2A). Based
on the evidence of pathological a-syn expression, we
then asked whether the endogenous a-syn protein increase
is caused by overproduction, accompanied by increased
a-syn transcripts, or by proteolytic dysfunction. qPCR of
oligodendrocyte lineage cells 72 hr after application of
a-syn PFFs clarified that there was no significant increase
in a-syn transcripts (Figure 2B).
Subsequently, we investigated the effect of 24-hr applica-
tion of a-syn PFFs on proteolytic systems in oligodendro-
cyte lineage cells. Immunoblot analysis of a-syn PFF-
treated cells revealed p62 accumulation and fraction
conversion of LC3-I to LC3-II in OPCs (Figures 2C and
2E), which are correlated with insufficient autophagic
clearance and autophagosome accumulation, respectively.(C) Immunoblot analysis with proteolytic markers discloses marked
increases in p62 and LC3-II in OPCs, suggesting the induction of an
autophagic pathway due to a-syn PFF application.
(D–G) Quantification of each proteolytic marker expression in
oligodendrocyte lineage cell is exhibited. (D and E) Autophagic
indicators, p62 and LC3-II/LC3-I, show increasing trends in a-syn
PFF-treated OPCs. (F) Cathepsin D protein expression is not
significantly affected by a-syn PFF application. (G) The expression
of lysine-48-linked ubiquitin chains is not affected by a-syn PFF
application. Mean ± SEM; n = 4, respectively, independent cultures;
one-way ANOVA, *p < 0.05, ***p < 0.001.
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These findings, as well as the increase of endogenous
a-syn, were also observed when OPCs were incubated
for 24 hr with an autophagy inhibitor, chloroquine
(Figures S3A–S3C). The interaction of a-syn and autophagy
markers (p62, Beclin-1, and LC3) as well as the intra-lyso-
somal localization of a-syn was verified by immunostain-
ing and LysoTracker probes, implying the possibility of
compromised lysosomal degradation (Figures S3D and
S3E). Conversely, the protein expression levels of p62 and
LC3-II in OLGs treated with a-syn PFFs only slightly
increased, which did not reach statistical significance.
Cathepsin D is one of the lysosomal enzymes that are
known to regulate cell homeostasis bymediating the degra-
dation of misfolded protein aggregates delivered to lyso-
somes via autophagy or endocytosis (Bae et al., 2015).
Although the a-syn PFF application did not affect the
cathepsin D protein expression levels in OPCs or OLGs,
the enzymatic activity analysis suggested the reduced
cathepsin D activity in a-syn PFF-treated OPCs (Figures
2C, 2F, and S3F).
Lysine-48-linked polyubiquitin chains are well estab-
lished as the signal for 26S proteasomal degradation (Grice
and Nathan, 2016). Both the OPCs and OLGs showed no
appreciable increase in lysine-48-linked ubiquitin chains
(Figures 2C and 2G). Taken together, these results indicate
that a-syn PFFs impair autophagy more severely in OPCs
compared with OLGs, leading to the accumulation of
endogenous a-syn proteins.
a-Syn PFFs Interfere with mRNA Expression Related to
Myelination and Neuronal Support in
Oligodendrocyte Precursor Cells
Media lactate dehydrogenase (LDH) and water-soluble
tetrazolium (WST) assays revealed that a-syn PFFs did not
cause acute cell death after 24-hr exposure (Figures S3G
and S3H). Therefore, we assessed the functional influence
of a-syn PFF application on OPCs.
RNA sequencing (RNA-seq) analysis in OPCs revealed
remarkable alterations in mRNA profiles associated with
OLG maturation and neuromodulation after 72-hr a-syn
PFF application (Figure 3A). As for the gene expression
involved in oligodendrocyte maturation, a-syn PFF
application to OPCs suppressed the gene expressions of
myelination-promoting factors such as Ackr3 (encoding
CXCR-7) and Cntn1 (encoding Contactin 1), while
increasing those of myelination-inhibiting factors such
as Sirt2 (encoding sirtuin 2) and Il1b (interleukin 1b).
Among the neurotrophic factors that regulate neurodegen-
erative disease pathology, monocarboxylate transporter 1
(MCT1) encoded by Slc16a1, which mediates neuronal
death through the release of lactate, and brain-derived neu-
rotrophic factor (BDNF) showed a tendency to decrease
(Lee et al., 2012). Therefore, we verified the alteration of360 Stem Cell Reports j Vol. 10 j 356–365 j February 13, 2018mRNA expression levels of Slc16a1 and Bdnf (Figures 3B
and 3C) as well as those of glial cell-derived neurotrophic
factor (Gdnf) and insulin-like growth factor-1 (Igf1) by
qPCR (Figures S3I and S3J). Interestingly, themRNA expres-
sion level of Slc16a1 was significantly suppressed, whereas
those of Bdnf and Gdnf were unchanged. The perturbation
of these neurotrophic factors induced by extracellular
a-syn PFFs wasmore severe inOPCs than in OLGs, possibly
reflecting the difference of a-syn internalization and sus-
ceptibility against seeding. Alterations ofmRNA expression
levels were observed in various profiles associated with pro-
teolysis and protein trafficking (Figure S3K), phenotypic
markers (Figure S3L), and risk genes for familial Parkinson’s
disease and MSA (Figure S3M). The results and interpreta-
tion of RNA-seq analysis regarding possible endocytic
players for a-syn PFF uptake in OPCs are described in the
Supplemental Information.
OPCs Pre-incubated with Recombinant Human a-Syn
PFFs Differentiate intoMature OLGs with Endogenous
a-Syn-Positive Inclusions
To determine if the endogenous a-syn accumulation in
OPCs remains even after differentiation into mature
OLGs, we tried to differentiate a-syn PFFs-treated OPCs ac-
cording to the procedure shown in Figure 4A. Immuno-
staining revealed a-syn aggregates in differentiated OLGs,
which were also immunoreactive to an endogenous a-syn
antibody (Figures 4B–4D). Immunoelectron microscopy
showed the intracellular existence of fibrillar a-syn (Fig-
ure S4A). An anti-phosphorylated a-syn antibody detected
vague immunoreactivity merged with a-syn aggregates
through immunostaining, nevertheless the immunoreac-
tivity was not detectable with immunoblot analysis (Fig-
ures S4B and S4C). Pre-incubation with a-syn PFFs also
caused a reduction in myelin-associated proteins, such as
myelin basic protein (MBP) and tubulin polymerization
promoting protein (TPPP/p25a) (Figures 4E, S4D, and
S4E). The decrease of these OLG-specific markers was
accompanied with an increase in the protein expression
levels of PDGFRa and a decreasing trend of Mbp mRNA
expression levels, suggesting insufficient differentiation
as a result of a-syn PFF application (Figures S4F–S4I).
In order to delineate the functional consequence
induced by a-syn PFF application before maturation, we
focused on the neuro-supportive function of conditioned
medium from OLGs (Figures 4F–4I). The equivalent me-
dium kept under the same conditions in culture flasks
without cells was used as control medium. Generally,
when primary neurons are incubated with full-medium
change, the survival of neurons is impaired compared
with half-medium change. The conditioned medium
from our OLG culture promoted the survival of primary
neurons even with full-medium change. Notably, this
Figure 3. RNA-Seq and qPCR Analysis for
mRNA Expression Alteration in a-Syn
PFF-treated OPCs
(A) RNA-seq analysis of a-syn PFF-treated
OPCs discloses a dramatic shift in the
expression of transcripts related to neuro-
modulation, myelination, and cell survival.
Each pair of OPC culture samples (OPC1,
OPC2, and OPC3) was allocated for the two
groups with and without a-syn PFF (3 mM)
application.
(B and C) qPCR elucidates reduced
mRNA expression of Slc16a1 in a-syn PFF
(3 mM)-treated OPCs, whereas Bdnf mRNA
expression is not significantly affected.
Mean ± SEM; n = 6, respectively; indepen-
dent cultures; paired t test, *p < 0.05.neuro-supportive effect was suppressed when OLGs were
differentiated from OPCs pretreated with a-syn PFFs.DISCUSSION
The existence of endogenous a-syn in primary oligoden-
droglial cell culture has been previously reported by
Richter-Landsberg et al. (2000). On the other hand, a previ-
ous report of in situ hybridization in GCI-rich regions re-
vealed no increase in a-syn mRNA expression in MSA
brains compared with controls (Miller et al., 2005). The
in vitro findings of endogenous a-syn accumulation as areflection of autophagic impairment in oligodendrocyte
lineage cells in our study (Figures 1D–1G) are in keeping
with both of the previous studies and suggested the possi-
bility that endogenous a-syn in oligodendrocyte lineage
cells per se contributes to the formation of a-syn aggregates
in MSA.
Macroautophagy is particularly important for patholog-
ical a-syn clearance, as it can degrade insoluble or aggre-
gated forms of proteins (Konno et al., 2012). In fact, GCIs
in MSA brains are immunoreactive to autophagic markers,
such as LC-3 and p62 (Schwarz et al., 2012). In addition,
the downregulation of a lysosomal enzyme, cathepsin D,
is associated with intracellular a-syn accumulation inStem Cell Reports j Vol. 10 j 356–365 j February 13, 2018 361
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SH-SY5Y cells and myelin degeneration in knockout mice
(Mutka et al., 2010; Bae et al., 2015). The lysosomal locali-
zation of a-syn, as well as the altered cathepsinD activity in
OPCs of our study, emphasizes the pathological relevance
of insufficient lysosomal degradation for a-syn accumula-
tion and disease progression in MSA patients (Figures S3E
and S3F).
Loss of neurotrophic support from oligodendrocytes
in MSA has been postulated as the mechanism for
neurodegeneration secondary to the primary glial pathol-
ogy (Fellner et al., 2011). The RNA-seq and qPCR analysis
corroborated that OPCs express comparable amounts of
transcripts related to neuro-supportive factors, such as
MCT1, BDNF, and GDNF (Figures S1H and 3). The lack
of metabolic support for neurons by oligodendroglial
MCT-1, a key player for the shuttling of lactate, results in
neuronal death, which potentially contributes to neuronal
degeneration in MSA (Lee et al., 2012). Furthermore, the
OLGs containing a-syn aggregates in our experiments
showed decreased expression levels of myelin-associated
proteins and compromised neuro-supportive function via
soluble factors (Figures 4E–4I). These findings are consis-
tent with a previous investigation that detected myelin
loss and neurodegeneration in the brains of transgenic
MSA mice overexpressing a-syn in OLGs (Shults et al.,
2005).
A limitation of the present study is that primary oligo-
dendrocyte lineage cell cultures can only be used in exper-
iments with relatively short incubation times due to the
short survival time of these cells. Thus, we conducted the
studies with higher concentrations of recombinant human
a-syn PFFs compared with the concentrations used in the
previous study of primary neurons (Volpicelli-Daley et al.,
2011). In consequence, our study could not clearly detect
phosphorylated a-syn immunoreactivity in oligodendrog-
lial cells, even with 7 days of incubation after a-syn PFFFigure 4. Cytoplasmic a-Syn Inclusions and Impaired Neuro-sup
Induction of a-Syn PFF-Treated OPCs
(A) Time chart of the experimental procedure is displayed. Cells are in
removal of extracellular a-syn PFFs and initiation of 7 days of matura
(B) Cytoplasmic a-syn inclusion is confirmed by confocal microscopy
(C) The cytoplasmic inclusions contain endogenous rat a-syn. The in
represents 20 mm.
(D) Percentages of OLGs containing cytoplasmic inclusions labeled wit
OLGs with and without a-syn PFF (1 mM) pretreatment before maturati
ANOVA, **p < 0.01.
(E) Immunoblot analysis reveals reduced myelin-associated proteins
maturation.
(F) Immunostaining of primary cortical neurons incubated with condit
of MAP2 and NeuN are induced by a-syn PFF (3 mM) pretreatment to
(G–I) Viability of primary neurons is evaluated by the quantification o
positive cells. Mean ± SEM; n = 4, respectively; independent culturesadministration (Figures S2H, S2I, S4B, and S4C). Consid-
ering that at least 7–10 days of the incubation period is
required for neuronal a-syn to be phosphorylated, a longer
observation period is warranted to confirm phosphoryla-
tion of a-syn in oligodendrocyte lineage cells with their
modest basal a-syn expression compared with neurons
(Volpicelli-Daley et al., 2011). As another limitation of
the present study, we administered a-syn PFFs to cultured
OPCs and OLGs to induce endogenous a-syn aggregation,
since this is the standard protocol for a-syn aggregate for-
mation in neurons (Volpicelli-Daley et al., 2011). However,
the primary pathogenesis by which oligodendrocytes spe-
cifically trigger the production of misfolded a-syn in MSA
is yet to be elucidated.
Overall, in vitro a-syn PFF administration in our primary
cultures recapitulated a critical aspect of MSA pathogenesis
and thus represents a practical model system. We suggest
that OPCs potentially play a role in MSA pathology
through internalization of extracellular a-syn and accumu-
lation of endogenous a-syn, and that manipulation of
a-syn expression in OPCs may serve as a therapeutic strat-
egy against GCI formation.EXPERIMENTAL PROCEDURES
Study Approval
Autopsied human brains were obtained from Kyoto University
Hospital through a process approved by an institutional research
committee. All animal procedures were performed according to
the guidelines of the Animal Use and Care Committee of Kyoto
University and of the Institute of Biomedical Research and
Innovation.Primary Oligodendrocyte Lineage Cell Cultures
Mixed glial cell cultures were obtained from cerebral cortices of
1- to 2-day-old Sprague-Dawley rats and prepared as previouslyportive Function in Mature OLGs Derived through Maturation-
cubated with a-syn PFFs (1 or 3 mM) for 24 hr followed by complete
tion.
. The scale bar represents 20 mm.
clusions are also labeled with Thioflavin S staining. The scale bar
h both endogenous rat a-syn and Thioflavin S are compared between
on. Mean ± SEM; n = 3, respectively; independent cultures; one-way
, MBP and TPPP/p25a, in OLGs pretreated with a-syn PFFs before
ioned medium from OLGs reveals that reduced neuronal expressions
OPCs before maturation. Each scale bar represents 50 mm.
f (G) WST assay, (H) MAP2-positive areas, and (I) numbers of NeuN-
; one-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001.
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described (Maki et al., 2015). Isolated OPCs were differentiated
into mature OLGs by incubation with differentiation medium
for 7 days.Preparation of Recombinant Human a-Syn
Recombinant human a-syn was purified in accordance with a
previously established method (Masuda-Suzukake et al., 2013).
PFFs were diluted in PBS at 1 mM or 3 mM, sonicated several times
(30–60 s in total), filteredwith 0.2-mmsyringe filters (Life Sciences),
and diluted in medium.Immunostainings Observed with Confocal Laser
Microscopy
An Olympus Fluoview FV1000 confocal microscope was used to
observe immunostaining with secondary antibodies conjugated
to fluorescein isothiocyanate, Texas red, or Cy5 (1:200, Alexa Fluor
488, 594, and 647).RNA-Seq Analysis of OPCs
Agilent SureSelect Strand Specific RNA prep kit (catalog no.
G9691A) was used with 200 ng of total RNA to construct cDNA
libraries.Statistical Analysis
All quantitative data were analyzed by using GraphPad Prism 5.0.ACCESSION NUMBERS
The GEO accession number for the full dataset of RNA-seq is GEO:
GSE107582; see https://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE107582 for more information and a full list of sup-
ported databases.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, one table, and two movies and can be
found with this article online at https://doi.org/10.1016/j.stemcr.
2017.12.001.AUTHOR CONTRIBUTIONS
S.K., study design, data acquisition and analysis, and drafting the
manuscript and figures; T.M., study conception and design, super-
vising the preparation of primary cultures and data acquisition,
and critical revision of the manuscript; H.K., N.U., and M.H., su-
pervising the preparation of a-synuclein; T.A. andW.K., histopath-
ological data acquisition and analysis; T.F., supervising electron
microscopic data acquisition and analysis; M.U. and K.I., study
conception, data interpretation, and critical revision of the manu-
script; Y.O. and Y.K., data acquisition by RNA-seq analysis; X.B.M.,
V.L.D., Q.T., and T.M.D., data acquisition and analysis and critical
revision of the manuscript for important intellectual content; R.T.,
funding, supervising, and critical revision of the manuscript for
important intellectual content.364 Stem Cell Reports j Vol. 10 j 356–365 j February 13, 2018ACKNOWLEDGMENTS
We thank all of our colleagues and staff at the Department of
Neurology, Graduate School of Medicine, Kyoto University,
including H. Yamashita, A. Kuzuya, H. Yamakado, M. Uemura,
M. Hishizawa, Y. Taruno, M. Ikuno, E. Nakanishi, M. Sawamura,
S. Okuda, K. Yasuda, S. Matsuzawa, Y. Hatanaka, R. Hikawa, and
R. Tamano for their expert advice. We thank Dr. M. Takahashi for
methodological suggestions on the immunoblot analysis. R.T.
is supported by Grants-in-Aid for Scientific Research (A)
(15H02540) and Grants-in-Aid for Scientific Research on Innova-
tive Area Brain Environment (23111002) from the Japan Society
for the Promotion of Science. T.M. is supported by Grants-in-Aid
for Scientific Research (C) (16K07056) from the Ministry of Educa-
tion, Culture, Sports, Science and Technology in Japan. X.B.M. is
supported by NIH/NIA Johns Hopkins ADRC P50 AG05146.
X.B.M., T.H.Q., V.L.D., and T.M.D. are supported by JPB and
NIH/NINDS grant P50 NS38377. T.M.D. is the Leonard and Mad-
lyn Abramson Professor in Neurodegenerative Diseases. X.B.M.,
V.L.D., and T.M.D. acknowledge the joint participation by the
Adrienne Helis Malvin Medical Research Foundation through its
direct engagement in the continuous active conduct of medical
research in conjunction with the Johns Hopkins Hospital and
the Johns Hopkins University School of Medicine and the founda-
tion’s Parkinson’s Disease Program M-2014.
Received: January 17, 2017
Revised: December 2, 2017
Accepted: December 4, 2017
Published: January 11, 2018REFERENCES
Angot, E., Steiner, J.A., Hansen, C., Li, J.Y., and Brundin, P. (2010).
Are synucleinopathies prion-like disorders? Lancet Neurol. 9,
1128–1138.
Bae, E.J., Yang, N.Y., Lee, C., Kim, S., Lee, H.J., and Lee, S.J. (2015).
Haploinsufficiency of cathepsin D leads to lysosomal dysfunction
and promotes cell-to-cell transmission of alpha-synuclein aggre-
gates. Cell Death Dis. 6, e1901.
Djelloul, M., Holmqvist, S., Boza-Serrano, A., Azevedo, C., Yeung,
M.S., Goldwurm, S., Frisen, J., Deierborg, T., and Roybon, L.
(2015). Alpha-synuclein expression in the oligodendrocyte line-
age: an in vitro and in vivo study using rodent and humanmodels.
Stem Cell Reports 5, 174–184.
Fellner, L., Jellinger, K.A.,Wenning,G.K., and Stefanova,N. (2011).
Glial dysfunction in the pathogenesis of alpha-synucleinopathies:
emerging concepts. Acta Neuropathol. 121, 675–693.
Grice, G.L., and Nathan, J.A. (2016). The recognition of ubiquiti-
nated proteins by the proteasome. Cell. Mol. Life Sci. 73, 3497–
3506.
Konno, M., Hasegawa, T., Baba, T., Miura, E., Sugeno, N., Kikuchi,
A., Fiesel, F.C., Sasaki, T., Aoki, M., Itoyama, Y., and Takeda, A.
(2012). Suppression of dynaminGTPase decreases alpha-synuclein
uptake by neuronal and oligodendroglial cells: a potent therapeu-
tic target for synucleinopathy. Mol. Neurodegener. 7, 38.
Lee, Y., Morrison, B.M., Li, Y., Lengacher, S., Farah,M.H., Hoffman,
P.N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.W., et al. (2012). Oligo-
dendroglia metabolically support axons and contribute to neuro-
degeneration. Nature 487, 443–448.
Levine, J.M., Reynolds, R., and Fawcett, J.W. (2001). The oligoden-
drocyte precursor cell in health and disease. Trends Neurosci. 24,
39–47.
Maki, T., Takahashi, Y., Miyamoto, N., Liang, A.C., Ihara, M., Lo,
E.H., and Arai, K. (2015). Adrenomedullin promotes differentia-
tion of oligodendrocyte precursor cells into myelin-basic-pro-
tein expressing oligodendrocytes under pathological conditions
in vitro. Stem Cell Res. 15, 68–74.
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai,
T., Akiyama, H., Mann, D.M., and Hasegawa, M. (2013). Prion-like
spreading of pathological alpha-synuclein in brain. Brain 136,
1128–1138.
May, V.E., Ettle, B., Poehler, A.M., Nuber, S., Ubhi, K., Rockenstein,
E., Winner, B., Wegner, M., Masliah, E., and Winkler, J. (2014).
alpha-Synuclein impairs oligodendrocyte progenitor maturation
in multiple system atrophy. Neurobiol. Aging 35, 2357–2368.
Miller, D.W., Johnson, J.M., Solano, S.M., Hollingsworth, Z.R.,
Standaert, D.G., and Young, A.B. (2005). Absence of alpha-syn-
uclein mRNA expression in normal and multiple system atro-
phy oligodendroglia. J. Neural Transm. (Vienna) 112, 1613–
1624.
Mutka, A.L., Haapanen, A., Kakela, R., Lindfors, M., Wright, A.K.,
Inkinen, T., Hermansson, M., Rokka, A., Corthals, G., Jauhiainen,
M., et al. (2010). Murine cathepsin D deficiency is associatedwith dysmyelination/myelin disruption and accumulation of cho-
lesteryl esters in the brain. J. Neurochem. 112, 193–203.
Richter-Landsberg, C., Gorath,M., Trojanowski, J.Q., and Lee, V.M.
(2000). alpha-synuclein is developmentally expressed in cultured
rat brain oligodendrocytes. J. Neurosci. Res. 62, 9–14.
Schwarz, L., Goldbaum, O., Bergmann, M., Probst-Cousin, S., and
Richter-Landsberg, C. (2012). Involvement of macroautophagy in
multiple system atrophy and protein aggregate formation in oligo-
dendrocytes. J. Mol. Neurosci. 47, 256–266.
Shults, C.W., Rockenstein, E., Crews, L., Adame, A.,Mante,M., Lar-
rea, G., Hashimoto,M., Song, D., Iwatsubo, T., Tsuboi, K., andMas-
liah, E. (2005). Neurological andneurodegenerative alterations in a
transgenicmousemodel expressing human alpha-synuclein under
oligodendrocyte promoter: implications for multiple system atro-
phy. J. Neurosci. 25, 10689–10699.
Volpicelli-Daley, L.A., Luk, K.C., Patel, T.P., Tanik, S.A., Riddle,
D.M., Stieber, A., Meaney, D.F., Trojanowski, J.Q., and Lee, V.M.
(2011). Exogenous alpha-synuclein fibrils induce Lewy body pa-
thology leading to synaptic dysfunction and neuron death.
Neuron 72, 57–71.
Wenning, G.K., Stefanova, N., Jellinger, K.A., Poewe, W., and
Schlossmacher, M.G. (2008). Multiple system atrophy: a primary
oligodendrogliopathy. Ann. Neurol. 64, 239–246.
Wilkins, A., Majed, H., Layfield, R., Compston, A., and Chandran,
S. (2003). Oligodendrocytes promote neuronal survival and axonal
length by distinct intracellular mechanisms: a novel role for
oligodendrocyte-derived glial cell line-derived neurotrophic factor.
J. Neurosci. 23, 4967–4974.Stem Cell Reports j Vol. 10 j 356–365 j February 13, 2018 365
Stem Cell Reports, Volume 10Supplemental InformationPathological Endogenous a-Synuclein Accumulation in Oligodendro-
cyte Precursor Cells Potentially Induces Inclusions in Multiple System
Atrophy
Seiji Kaji, Takakuni Maki, Hisanori Kinoshita, Norihito Uemura, Takashi Ayaki, Yasuhiro
Kawamoto, Takahiro Furuta, Makoto Urushitani, Masato Hasegawa, Yusuke
Kinoshita, Yuichi Ono, Xiaobo Mao, Tran H. Quach, Kazuhiro Iwai, Valina L. Dawson, Ted
M. Dawson, and Ryosuke Takahashi
Supplemental Information: Extended Experimental Procedures 
 
Pathological Endogenous α-Synuclein Accumulation 
in Oligodendrocyte Precursor Cells Potentially 
Induces Inclusions in Multiple System Atrophy 
 
Authors: Seiji Kaji, MD, Takakuni Maki, MD, PhD, Hisanori Kinoshita, MD, Norihito Uemura, MD, 
PhD, Takashi Ayaki, MD, PhD, Yasuhiro Kawamoto, MD, PhD, Takahiro Furuta, PhD, Makoto 
Urushitani, MD, PhD, Masato Hasegawa, PhD, Yusuke Kinoshita, Yuichi Ono, PhD, Xiaobo Mao, 
PhD, Tran H. Quach, Kazuhiro Iwai, MD, PhD, Valina L. Dawson, PhD, Ted M. Dawson, MD, PhD, 
Ryosuke Takahashi, MD, PhD 
 
 
Inventory of Supplemental Information 
Extended Experimental Procedures 
Supplemental Results 
Supplemental Discussion 
Supplemental References 
Supplemental Table 
Table S1, related to Figure 3 
Supplemental Figures S1-S4 
Figure S1, related to Figure 1 
Figure S2, related to Figure 1 
Figure S3, related to Figure 2 and 3 
Figure S4, related to Figure 4 
Supplemental Movies S1-S2 
Supplemental Movie S1, related to Figure 1 
Supplemental Movie S2, related to Figure 1 
  
Supplemental Experimental Procedures: 
Histopathological Analysis of MSA Patients 
For histopathological analysis, formalin-fixed, paraffin-embedded 6-μm-thick sections from the pons of 
MSA patients were deparaffinized and immunostained. We applied primary antibodies for α-synuclein 
(α-syn) (1:200, BD Biosciences, 610787) and NG2 (1:200, Merck Millipore, AB5320) and incubated 
overnight at 4℃. Subsequently to incubation with secondary antibodies (1:200, Alexa Fluor 594 and 647, 
A21207, A31571) for 1 hour at room temperature, sections were covered with VECTASHIELD mounting 
medium (Vector Laboratories) with DAPI. For Thioflavin S assessment, sections were incubated with 20 
µM Thioflavin S (Sigma Aldrich) in distilled water for 20 min at room temperature before mounting. 
Images were obtained using a confocal microscopy as described below. Procedures involving the use of 
human materials were performed in accordance with ethical guidelines set by Kyoto University. 
 
Primary Cell Cultures 
Primary oligodendrocyte lineage cell and other glial cell culture 
OPCs were prepared as previously described (Maki et al., 2015). Briefly, cerebral cortices from 1- to 2- 
day-old Sprague Dawley rats (Shimizu Laboratory Supplies Co., Ltd) were dissected, minced, and 
digested. Dissociated cells were plated in poly-D-lysine-coated 75 cm
2
 flasks, and maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing 20% heat-inactivated fetal bovine serum and 
1% penicillin/streptomycin. After the cells were confluent (~10 days), the flasks were shaken for 1 hour 
on an orbital shaker (220 rpm) at 37°C to remove microglia. The flasks were then changed to new 
medium and shaken overnight (~20 hours). The medium was collected and plated on non-coated tissue 
culture dishes for 1 hour at 37°C to eliminate contaminating astrocytes and microglia. The non-adherent 
cells (OPCs) were collected and replated at a density of 20,000 cells/cm
2
 in Neurobasal (NB) medium 
containing 2 mM glutamine, 1% penicillin/streptomycin, 10 ng/ml PDGF-AA, 10 ng/ml FGF-2 and 2% 
B27 supplement onto poly-DL-ornithine-coated plates. Four to 6 days after plating, the OPCs were used 
for the experiments. To differentiate OPCs to mature oligodendrocytes, the culture medium was switched 
to DMEM containing 1% penicillin/streptomycin, 10 ng/ml CNTF, 15 nM T3 and 2% B27 supplement. 
Seven days after switching medium, the mature oligodendrocytes were used for the experiments. To 
obtain astrocytes, non-astrocytic cells were detached from the flasks with mixed glial cells by shaking and 
removing the medium. Then, astrocytes were dissociated by tripsinization and subsequently replated at a 
density of 200,000 cells/cm
2
. 
 
Primary neuronal cell culture 
Cortical neuronal cultures were prepared from 17-day-old Sprague Dawley rat embryos (Shimizu 
Laboratory Supplies Co., Ltd) using methods described earlier (Maki et al., 2014). Briefly, cortices were 
dissected and dissociated. Cells were plated on dishes coated with poly-D-lysine in DMEM containing 
5% fetal bovine serum and 1% penicillin/streptomycin at a density of 200,000 cells/cm
2
. At 24-hour after 
seeding, the medium was changed to NB medium containing 0.5 mM glutamine, 1% 
penicillin/streptomycin and 2% B27 supplement. Cultured neurons were used for experiments 14 days 
after seeding. 
 
Preparation of Recombinant Human α-Syn PFFs 
Purification was conducted in accordance with previously established method (Masuda-Suzukake et al., 
2013). Human wild-type α-syn cDNA was cloned into the bacterial expression vector pRK172. 
Transformations and selection were performed using E. coli BL-21(DE3) competent cells (BioDynamics) 
and ampicillin (100 μg/ml) in Luria-Bertani media. Following overnight incubation of transformed cells 
in Luria-Bertani media containing ampicillin (100 μg/ml) at 37 °C, the culture was incubated for another 
5 hours after 300-fold dilution and then induced with 1mM isopropyl-β-D-thiogalactopyranoside for 5 
hours at 37 °C. Bacterial pellets were resuspended in high-salt buffer (1M Tris-HCl, pH 7.5, 1 mM 
EDTA), heated to 100 °C for 5 min, and centrifuged at 15,000 rpm for 15 min. The supernatants were 
subjected to chromatography on a Q-Sepharose fast-flow column (GE healthcare) with a gradient of 0 to 
0.5 M NaCl in Tris buffer. The proteins were dialyzed overnight against 50 mM Tris-HCl, 150 mM KCl, 
pH 7.5 and centrifuged at 55,000 rpm at 4°C for 20 min. The supernatants were filtered with 0.2 μm 
syringe filters (Life Sciences) and diluted in media for experimental use as monomeric α-syn. For PFFs 
formation, proteins were incubated with constant agitation at 37°C for 3-7 days. α-Syn PFFs were diluted 
in PBS at 1 µM or 3 µM, sonicated several times (30-60 seconds in total), filtered with 0.2 μm syringe 
filters (Life Sciences), and diluted in media. For observation with confocal and immunoelectron 
microscopy, 3 µM and 1 µM α-syn PFFs or monomer were prepared, respectively. The fractions were 
assayed for the presence of the α-syn proteins by SDS-polyacrylamide gel electrophoresis (PAGE) 
followed by Coomassie Blue R-250 staining. Protein concentration was determined using the 
bicinchoninic acid protein assay (Thermo Fisher) and bovine serum albumin as a standard. 
 
Incubation of OPCs with Autophagy-Modifying Drugs 
To assess how altered autophagic states affect the endogenous α-syn expression and autophagic markers 
in OPCs, we incubated OPCs for 24 hours with 10 μM chloroquine (Enzo Life Science), a lysosomal 
inhibitor, or 500 nM rapamycin (Enzo Life Science), an autophagy inducer. 
 
Differentiation of OPCs Pre-incubated with α-Syn PFFs 
1 µM or 3 µM α-syn PFFs were added to OPCs culture when its confluency reaches 60%. Subsequently 
to 24-hour incubation with α-syn PFFs, cells were washed twice with fresh medium not containing α-syn 
PFFs. Medium was switched to DMEM containing 1% penicillin/streptomycin, 10 ng/ml CNTF, 15 nM 
T3 and 2% B27 supplement. After 7 days of incubation, the mature oligodendrocytes were used for the 
experiments. 
 
Incubation of Primary Cortical Neurons with Conditioned Medium from OLGs 
Primary cortical neuron culture was incubated for 72 hours either 1) with conditioned medium from 
normal OLGs, 2) with conditioned medium from OLGs differentiated from OPCs preincubated with 
α-syn PFFs (3 μM), or 3) with neuron medium incubated for 24 hours in no cell plate (serves as control). 
Conditioned medium was prepared from neuron medium (NB medium containing 0.5 mM glutamine, 1% 
penicillin /streptomycin and 2% B27 supplement) which were incubated for 24 hours with mature OLGs 
differentiated from OPCs with or without α-syn PFFs preincubation (as illustrated in Fig. 4A). 
 
Time-Lapse Imaging 
Time-lapse imaging was performed with BZ-X710 (Keyence) equipped with an incubator (37°C and 5% 
CO2) by acquiring images at defined positions every 10 minutes. Images were converted to AVI files. 
 
Cathepsin D activity Assay 
The enzymatic activity of cathepsin D in OPCs was measured by cathepsin D assay kit (AnaSpec) 
according to the manufacturer’s instructions. Cathepsin activity was determined by kinetic analysis, 
which calculates the initial reaction velocity in relative fluorescence units (RFU) per minute. RFU change 
during the first 5 minutes of the reaction was used for the calculation. 
 
Cytotoxicity and Cell Survival Assay with Media LDH and WST Assay 
Cytotoxicity was assessed by media LDH assay kit (Cytotoxicity LDH Assay Kit-WST, Dojindo). LDH is 
rapidly released into the cell-culture supernatants when the plasma membrane is damaged. 100 µl of the 
supernatants is incubated with the same amount of substrate mixture from the kit for 30 min. Then the 
absorbance of the culture medium was measured with a microplate reader at a test wavelength of 490 nm. 
Cell proliferation/survival was assessed by WST reduction assay kit (Cell Counting Kit-8, Dojindo). WST 
assay is a sensitive colorimetric method to detect cell viability. The cells were incubated with 10% WST 
solution for 1 hour at 37°C. The absorbance of the culture medium was measured at a wavelength of 450 
nm and a reference wavelength of 630 nm. 
 
Immunostainings with Confocal Microscopy 
After washing the cells twice with PBS, the cells were fixed with 4% PFA for 15 min. After washing 
twice with PBS, incubation with PBS/0.1%Tween (10 min) and blocking with 3%BSA/PBS (1 hour at 
room temperature), the cells were incubated with primary antibodies against PDGFRα (1:200, R&D 
systems, AF1062), MBP (1:200, MBL, PD004 or 1:200, Thermo Fisher Scientific, MA1-10837), α-syn 
(recognizes human and rat) (1:200, BD Biosciences, 610787), rat α-syn (1:200, CST, 4179S), human 
α-syn (1:200, Thermo Fisher Scientific, 180215), TPPP/p25α (1:200, Abcam, ab92305), p62 (200:1, MBL, 
PM045), Beclin-1 (200:1, Santa Cruz, sc-10086), LC3 (300:1, MBL, PM036), phosphorylated α-syn 
(1:200, Abcam, ab51253), MAP2 (300:1, Sigma Aldrich, M1406) and NeuN (300:1, Merck Millipore, 
ABN78) at 4°C overnight. For the validation of endogenous α-syn expression in OPCs, we used 
Mouse-IgG (200:1, Vector Laboratories, BA-2000) as a primary antibody for negative control. 
Subsequently, after washing with PBS, they were incubated with secondary antibodies (1:200, Alexa 
Fluor 488, 594 and 647, A21202, A21203, A31571, A21206, A21207, A31573, A11055, A11058, 
A21447) for 1 hour at room temperature. After washing with PBS, the cells were covered with 
VECTASHIELD mounting medium (Vector Laboratories) with DAPI. The cells were observed by 
Olympus Fluoview FV1000 confocal microscope (Olympus). As for Thioflavin S staining, cells were 
incubated with 20 µM Thioflavin S (Sigma Aldrich) in distilled water for 20 min at room temperature 
before mounting. Image analysis and 3D surface reconstruction were performed by FV10-ASW software 
(Olympus). Sections were imaged at 0.124 µm/pixel resolution in xy dimension and 0.4 µm in z 
dimension. Regarding the use of the LysoTracker (Life technologies) probes, cells were incubated with 
probe-containing medium (50 nM) for 30 minutes, before the wash with PBS and fixation. The following 
immunostaining was conducted as described above. 
 
Immunoelectron Microscopy 
Immunoelectron microscopy using ultrathin cryosections was performed as described. Briefly, cells were 
washed with PBS twice, immersed in 4% PFA with 0.1% glutaraldehyde at 4°C for 2 hours. Following 60 
min pre-treatment with 3% BSA in PBS used for blocking agents containing 0.1 % Photo-Flo (EMS), the 
samples were incubated overnight at 4°C with mouse anti-α-syn antibody (1:200, BD Biosciences, 
610787). They were then incubated with Nanogold goat anti-mouse IgG conjugates (1:100, Nanoprobes, 
2002) overnight at 4°C. Immunostained sections were fixed with 1% glutaraldehyde in 0.1M PB. To 
better visualize the particles, the samples were reacted with Silver Enhancement Kit solutions 
(Nanoprobes) The sections were then washed with 0.1 M PB, placed for 40 min in 0.1 M PB containing 
1% osmium tetroxide, dehydrated, and embedded in epoxy resin (Luveak 812; Nacalai Tesque, Kyoto, 
Japan). After polymerization of the resin, each tissue sample was cut into 70-nm-thick ultrathin sections 
with a diamond knife on an ultramicrotome (Leica EM UC6 , Heiderberg, Germany), and mounted on 
coated copper grids (Stork Veco, Eerbeek, The Netherlands). The sections were finally examined with an 
electron microscope (H-7650; Hitachi, Tokyo, Japan) at 80 kV (Kameda et al., 2012).  
 
Immunoblot Analysis 
Cells were rinsed twice with PBS and collected into sample buffer containing 50% Tris-Glycine SDS 
buffer (Novex), 45% RIPA buffer (20 mM HEPES-KOH pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% 
Nonidet-P40, 1% sodium deoxycholate), 5% 2-mercaptomethanol (Nacalai tesque),.1% phosphatase 
inhibitor (Nacalai tesque) and 1% protease inhibitor (Nacalai tesque). Subsequently, samples were heated 
at 95°C for 5 min, and each sample was loaded onto 5–20% or 15 % polyacrylamide gel (Wako). After 
electrophoresis and transferring onto a PVDF membrane (Merck Millipore), the membranes were fixed 
with 4%PFA for 30 min and blocked in Tris buffered saline with 0.1% Tween 20 (TBS-T) containing 5% 
nonfat dry milk for 60 min at room temperature. Membranes were then incubated overnight at 4°C with 
primary antibodies for α-syn (recognizes human and rat) (1:1000, BD Biosciences, 610787), rat α-syn 
(1:1000, CST, 4179S), human α-syn (1:500, Thermo Fisher Scientific, 180215), PDGFRα (1:500, R&D 
systems, AF1062), MBP (1:1000, Thermo Fisher Scientific, MA1-10837), TPPP/p25α (1:500, Abcam, 
ab92305) GFAP (1:5000, Thermo Fisher Scientific, 13-0300), NeuN (3000:1, Merck Millipore, ABN78), 
GAPDH (500:1, Santa Cruz Biotechnology, sc-25778), HSP90α (1:5000, Abcam, ab133491), sodium 
potassium ATPase (1:5000, Abcam, ab76020), p62 (500:1, MBL, PM045), LC3 (500:1, MBL, PM036), 
Beclin-1 (500:1, Santa Cruz, sc-48341), cathepsin D (500:1, Santa Cruz Biotechnology, sc-6486), 
lysine-48-specific ubiquitin (Merck Millipore, 1000:1, 05-1307) or anti-β-actin antibody (1:10000, Sigma 
Aldrich, A5441), followed by 60 min incubation with secondary goat or donkey anti-IgG HRP antibodies 
(Santa Cruz Biotechnology, NA9310V, NA9340V, NB7115, NB7357) and visualization by enhanced 
chemiluminescence (Nacalai tesque). Assessment of Triton-insoluble SDS-soluble fractions was 
conducted as previously described (Uemura et al., 2015). Cells were homogenized in lysis buffer 
containing 1% Triton X-100 (150 mM NaCl, 50 mM Tris-HCl, 1% Triton X-100, pH 7.5) and centrifuged 
at 55,000 rpm at 4°C for 30 min. The supernatants were used for Triton soluble fractions. For 
SDS-soluble fractions, the pellet was rinsed with the lysis buffer, centrifuged again at 55,000 rpm at 4°C 
for 30 min followed by removal of the supernatant. Subsequently, the pellet was sonicated in SDS buffer 
(50 mM Tris-HCl, 2% SDS, pH 7.4) followed by centrifugation at 55,000 rpm at 4°C for 30 min. The 
supernatant was boiled in sample buffer (1% SDS, 12.5% glycerol, 0.005% bromophenol blue, 2.5% 
2-mercaptoethanol, 25 mM Tris-HCl, pH 6.8). Samples containing 20 μg of proteins were loaded onto 
each lane of 10 % Bis-Tris gels (Novex) for both fractions. The following procedure was performed as 
mentioned above. Each band was quantified with image J or ImageQuant software (GE healthcare) 
(Schneider et al., 2012). 
 
Subcellular Fractionation 
Trident Membrane Protein Extraction Kit (GeneTex) was used for subcellular fractionation. Extraction of 
cytosolic and plasma membrane fraction was conducted according to the manufacturer’s instructions. 
 
RNA-seq Analysis in OPCs 
Library construction and sequencing 
RNA-Seq library and sequencing: Agilent SureSelect Strand Specific RNA prep kit (Cat# G9691A) was 
used with 200ng of total RNA for the construction of cDNA libraries according to the manufacturer’s 
protocol. All cDNA libraries were sequenced using an Illumina Miseq, producing 76×2 bp paired-end 
reads with multiplexing. 
 
Bioinformatics analysis 
All raw sequencing reads were trimmed using Trimmomatic software (Bolger et al., 2014). Bases and QC 
assessment of sequencing were generated by FastQC. QC-passed reads were aligned to the Ensembl Rnor 
6.0.84 reference genome using Star v2.5.0c (Dobin et al., 2013). The abundance of transcripts was then 
estimated using an Expectation-Maximization algorithm implemented in the software package Cufflnk 
v2.2.1 [http://cole-trapnell-lab.github.io/cufflinks/]. Drawing heatmap of the RNA-seq data was 
performed using R software and the ggplot2 package  
 
Quantitative Real-time PCR 
RNA was extracted from cells with RLT lysis buffer (QIAGEN) according to the manufacturer’s 
instructions. RNA concentration was measured by NanoDrop 1000 spectrometer (Thermo Scientific). 
cDNA was generated with reverse transcription using the PrimeScript RT reagent kit (TaKaRa). The 
amount of cDNA was quantified with real-time PCR using LightCycler 480 SYBR Green I Master 
(Roche) and Roche LightCycler 480. The primer sets used in this study is listed in Table S1, thereafter. 
 
Statistical Analysis 
All quantitative data were analyzed using Prism 5.0 (Graphpad). Statistical significance was evaluated 
using a paired t-test or a one-way ANOVA followed by Tukey’s honestly significant difference test for 
multiple comparisons. Data are expressed as mean ± S.D. A p-value of <0.05 was considered statistically 
significant. 
 
 
 
Supplemental Results: 
α-Syn PFF Receptor Membrane Proteins in Oligodendrocyte Lineage Cells 
A recent report using primary neurons suggested that lymphocyte-activation gene 3 (LAG3) selectively 
binds to α-syn PFFs and mediates endocytosis as well as cell-to-cell transmission (Mao et al., 2016). 
Unexpectedly, our RNA-seq analysis suggested that the basal gene expression levels of Lag3 in OPCs 
were very low (Fig. S3K). The LAG3 protein expression in OPCs was also relatively low in immunoblot 
analysis (data not shown), and the pathological function of LAG3 in oligodendrocyte lineage cells 
remains unclear. 
 
 
Supplemental Discussion: 
Our studies demonstrated the predominance of α-syn internalization and susceptibility against seeding in 
OPCs, and indicated the possibility that OPCs are more relevant to the propagation of misfolded α-syn 
than OLGs. As is previously demonstrated with neurons, internalization of exogenous α-syn in 
oligodendroglial cells is presumably mediated by endocytosis (Konno et al., 2012; Mao et al., 2016). In 
fact, according to our RNA-seq analysis, the gene expressions of endocytic proteins such as Rab5a, 
Rab7a and Rab7b in OPCs seemed to increase after α-syn PFFs application (Fig. S3K). Nevertheless, the 
gene expressions of possible candidate receptors for misfolded α-syn, such as clathrin and LAG3, 
remained basically unchanged. A variety of endocytic pathways need to be scrutinized to unravel the 
seeding mechanisms lying behind our in vitro study results. In our study, however, the involvement of 
endocytic pathway was difficult to confirm, due to the limited tolerability of primary OPCs against the 
cytotoxicity of dynamin or clathrin inhibitor. In terms of in vivo propagation of misfolded α-syn, injection 
of α-syn PFFs into brains usually leads to α-syn aggregate formation exclusively in neurons. As far as 
OPCs are concerned, sparse basal expression levels of an α-syn PFF receptor protein, LAG3, may be 
consistent with these in vivo observations. 
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Table S1 Table of Primers Used in This Study 
 
Gene name Abbreviations Direction Sequences 
α-synulcien Snca 
F CAACAGTGGCTGAGAAGACC 
R GAAGGCATTTCATAAGCCTC 
Platelet-derived growth 
factor receptor, α 
Pdgfra 
F CTAATTCACATTCGGGAAGGTTG 
R GGACGATGGGCGACTAGAC 
Oligodendrocyte 
transcription factor 2 
Olig2 
F GACGACATTATGGGCTTTGATGG 
R GTTTCTGCCTGAACAGTCCAC 
Neural/Glial antigen 2 Cspg4 
F ATGCCCACTGTAGCCAAAAG 
R GTGTCACCAGCTAGGCCATT 
Nestin Nes 
F CGCCGCTACTTCTTTTCAAC 
R GCAGCTGGTTTTGCTCTTCT 
Myelin basic protein Mbp 
F ACACACAAGAACTACCCACTACGG 
R AGCTAAATCTGCTGAGGGACAG 
Myelin associated 
glycoprotein 
Mag 
F ATTCCGAATCTCTGGAGCAC 
R ACTCAGCCAGCTCCTCTGTC 
Glial fibrillary acidic 
protein 
Gfap 
F AGAAAACCGCATCACCATTC 
R GCACACCTCACATCACATCC 
Neuron-specific class Ⅲ 
β-tublin (Tuj-1) 
Tubb3 
F ACTTTATCTTCGGTCAGAGTG 
R CTCACGACATCCAGGACTGA 
Monocarboxylate 
transporter (MCT-1) 
Slc16a1 
F CTTGTGGCGTGATCCT 
R GTTTCGGATGTCTCGGG 
Brain-derived 
neurotrophic factor 
Bdnf 
F ATAGGAGACCCTCCGCAACT 
R CTGCCATGCATGAAACACTT 
Glial cell line-derived 
neurotrophic factor 
Gdnf 
F GCGGTTCCTGTGAAGCGGCCGA 
R TAGATACATCCACACCGTTTAGCGG 
Insulin like growth 
factor 1 
Igf-1 
F CAGTTCGTGTGTGGACCAAG 
R GTCTTGGGCATGTCAGTGTG 
Glyceraldehyde-3-phosp
hate dehydrogenase 
Gapdh 
F TCCCGCTAACATCAAATGGG 
R CCATCCACAGTCTTCTGAGT 
F; forward, R; reverse 
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Figure S1 Identification of α-Syn Accumulation in OPCs of an MSA Brain, and In Vitroα-Syn 
Expression in Primary Oligodendrocyte Lineage Cell Culture 
MSA Brain 
(A) The NG2
+
 OPC contains Thioflavin S-immunopositive aggregates, which are immunoreactive to 
α-syn in the pons of an MSA patient. The images were acquired by confocal microscopy. The 
white asterisks indicate erythrocytes. The scale bar represents 10µm. 
 
Primary Oligodendrocyte Lineage Cells 
(B) Confocal microscopy reveals α-syn immunoreactivity in both the cytoplasm of OPCs and OLGs. 
The scale bars represent 20 µm. 
(C) The α-syn immunoreactivity in OPCs is guaranteed by validating the difference between 
immunostaining results with mouse-IgG and anti-α-syn antibody (mouse-derived). The scale 
bars represent 20 µm. 
(D) Immunoblot analysis with an anti-α-syn antibody and antibodies against each cell-type marker 
illustrates α-syn expression in oligodendrocyte lineage cells as well as sufficiently high cell 
purity of each primary culture. 
(E) Quantification of α-syn expression in each cell type by immunoblot analysis verifies the 
appreciable levels of α-syn protein expressions in oligodendrocyte lineage cells. Relative α-syn 
expressions in glial cells with respect to that in neurons are illustrated. Mean±SEM; n=3, 
respectively; independent cultures; one-way ANOVA, *p<0.05 (compared with neuronal 
expression). 
(F) Quantitative real-time PCR analysis confirms the Snca mRNA expression in each cell-type 
culture. Mean±SEM; n=6 for OPCs and OLGs, n=3 for astrocytes and neurons; independent 
cultures; one-way ANOVA, *p<0.05 (compared with neuronal expression).  
(G) The purity of OPC culture is validated by immunostaining using antibodies against PDGFRα, 
GFAP, and NeuN. The scale bar represents 100µm. Cell numbers per each ×175 magnified 
visual field were quantified. Mean±SEM; n=3, respectively; one-way ANOVA, ***p<0.001. 
(H) Quantitative real-time PCR shows each cell marker transcript and neuromodulating factors. 
Mean±SEM; n=6 for OPCs and OLGs, n=3 for astrocytes and neurons, independent cultures. 
(I) Validation of primers used for quantitative real-time PCR is shown. 
  
P=0.002 
P
e
rc
e
n
ta
g
e
 o
f 
c
e
ll
s
 w
it
h
  
ra
t 
α
-s
y
n
 /
 T
h
io
fl
a
v
in
 S
 d
o
u
b
le
 
p
o
s
it
iv
e
 c
y
to
p
la
s
m
ic
 i
n
c
lu
s
io
n
s
 
C 
F 
E 
Supplemental Figure S2 
α-syn + PDGFRα + DAPI PDGFRα + DAPI α-syn 
MBP + DAPI α-syn 
α-syn + DAPI 
α-syn + DAPI α-syn + MBP + DAPI 
O
P
C
 
O
L
G
 
25 
15 
50 
37 
75 
100 
20 
(kDa) * 
* Indicates non-specific bands 
37 
β-actin 
P
h
o
s
p
h
o
ry
la
te
d
 α
-s
y
n
 
Days from α-syn PFFs 
application  1 1 2 3 7 7 
α-syn PFFs 
concentration (µM) 0 3 3 3 3 0 
25 
15 
50 
37 
75 
100 
150 
20 
37 
(kDa) 
β-actin 
R
a
t 
α
-s
y
n
 
α-syn concentration (µM) 
applied to OPCs 
PFFs 
monomer - 
- 
1 
- 
- 
1 
3 
- 
- 
3 
* 
* Indicates non-specific bands 
(kDa) 
Neuron 
36 
17 
β-actin 
α-syn PFFs 
concentration (μM) 
0 1 3 
R
a
t 
 α
-s
y
n
 
36 
17 H
u
m
a
n
 
α
-s
y
n
 
43 
28 
1 
In culture 
medium 
In buffer 
No cell 
P
h
o
s
p
h
o
ry
la
te
d
  
α
-s
y
n
  
+
 D
A
P
I 
24 hrs 48 hrs 72 hrs 7 days 
Incubation period after extracellular α-syn PFFs application 
R
a
t 
α
-s
y
n
 
H
u
m
a
n
 
α
-s
y
n
 
R
a
t 
+
 h
u
m
a
n
 
α
-s
y
n
 
HSP90α 
Sodium Potassium 
ATPase 
α-syn PFFs 
OPC OLG 
+ - + - + - + - 
15 
37 
37 
37 
100 
100 
(kDa) 
20 
10 
15 
20 
10 
15 
20 
10 
C C C C M M M M 
A B 
G H 
I 
Rat α-syn PDGFRα + DAPI Merge  
O
P
C
 
MBP + DAPI Rat α-syn Merge 
O
L
G
 
D 
Rat α-syn + 
PDGFRα + DAPI Thioflavin S Rat α-syn 
Rat α-syn + 
Thioflavin S + DAPI 
Rat α-syn + 
MBP + DAPI Thioflavin S Rat α-syn 
Rat α-syn + 
Thioflavin S + DAPI 
O
P
C
 
O
L
G
 
Rat α-syn Thioflavin S PDGFRα + DAPI 
Rat α-syn + 
PDGFRα + DAPI 
Rat α-syn Thioflavin S MBP + DAPI 
Rat α-syn + 
MBP + DAPI 
Figure S2 Characterization of Cytoplasmic Inclusions in Oligodendroglial Cells; Extracellular 
α-Syn PFFs Trigger the Aggregation of Endogenous Rat α-Syn Predominantly in OPCs 
(A) Confocal microscopy of OPCs and OLGs incubated with recombinant human α-syn monomer (3 
µM) shows no evident cytoplasmic α-syn accumulation. The primary antibody used for the 
immunostaining recognizes both exogenous human and endogenous rat α-syn. Each scale bar 
represents 10 µm. 
(B) Subcellular fractionation of OPCs and OLGs shows cytosolic accumulation of endogenous rat 
and exogenous human α-syn in OPCs in response to 24-hour incubation with recombinant 
human α-syn pre-formed fibrils (α-syn PFFs). Dimerization of endogenous rat α-syn is also 
observed in the cytosolic fraction in OPCs. C = cytoplasmic fraction; M = plasma membrane 
fraction. 
(C) Immunoblot analysis of primary rat neurons verifies the specific detection of endogenous α-syn 
by the rat-specific anti-α-syn antibody. The far right lane represents 1 μM of α-syn PFFs without 
cell lysates, which is recognized only with human-specific anti-α-syn antibody guaranteeing the 
specificity of each antibody. Endogenous rat α-syn in neurons is also multimerized by 24-hour 
incubation with α-syn PFFs. 
(D) Enhanced immunoreactivity of endogenous rat α-syn is observed predominantly in α-syn 
PFFs-treated OPCs labeled with PDGFRα. OLGs are labeled with MBP. The scale bar 
represents 20 µm. 
(E) Magnified views of α-syn PFFs-treated oligodendroglial cells by confocal microscopy reveal 
Thioflavin S-positive inclusions extensively observed in OPCs, but not in OLGs. Each 
magnified oligodendroglial cell corresponds to the cells surrounded by the dotted yellow lines. 
Each scale bar represents 20 µm. 
(F) Percentages of cells containing endogenous rat α-syn/Thioflavin S double-positive inclusions 
are quantified in OPC and OLG culture. The intracellular localization of each inclusion is 
confirmed by each cell marker, PDGFRα or MBP. Mean±SEM; n=3, respectively; independent 
cultures; one-way ANOVA. 
(G) Immunoblot analysis of OPCs incubated with monomeric or fibrillar recombinant human α-syn 
shows different response of endogenous rat α-syn expressions. Multimerization is not observed 
with the application of monomeric α-syn. 
(H)  (I) Phosphorylated α-syn is not detected within a timeframe of 7 days after α-syn PFFs (3 µM) 
application to OPCs. Each scale bar represents 10 µm. 
  
G H 
Ig
f1
 m
R
N
A
 e
x
p
re
s
s
io
n
 
N
o
rm
a
li
z
e
d
 2
-(
Δ
C
t)
 q
u
a
n
ti
fi
c
a
ti
o
n
 
G
d
n
f 
m
R
N
A
 e
x
p
re
s
s
io
n
 
N
o
rm
a
li
z
e
d
 2
-(
Δ
C
t)
 q
u
a
n
ti
fi
c
a
ti
o
n
 
J I 
control 
α-syn 
PFFs (+) 
control 
α-syn 
PFFs (+) 
* 
control 
α-syn 
PFFs (+) 
control 
α-syn 
PFFs (+) 
Supplemental Figure S3 
α-syn LysoTracker Merge + DAPI 
LDH activity 
OPC OLG 
α-syn 
PFFs 
α-syn 
PFFs 
OPC OLG 
α-syn 
PFFs 
α-syn 
PFFs 
WST activity 
L M 
E 
D α-syn + DAPI p62 + DAPI Merge α-syn + DAPI Beclin-1 + DAPI Merge 
α-syn + DAPI LC-3 + DAPI Merge 
Chloroquine (10µM) 
Rapamycin (500nM) 
Rat α-syn 
β-actin 
LC3-Ⅰ 
LC3-Ⅱ 
p-62 
17 
(kDa) 
55 
Beclin-1 
17 
55 
43 
- + - 
+ - - 
Chloroquine (10µM) 
Rapamycin (500nM) 
+ 
+ - - 
- - 
*** 
*** 
Chloroquine (10µM) 
Rapamycin (500nM) 
+ 
+ - - 
- - 
* * 
C A B 
α-syn 
PFFs 
*** 
** 
F 
C
a
th
e
p
s
in
 D
 a
c
ti
v
it
y
, 
k
in
e
ti
c
 a
n
a
ly
s
is
 
R
e
a
c
ti
o
n
 v
e
lo
c
it
y
 (
R
F
U
/m
in
),
  
p
e
rc
e
n
t 
o
f 
c
o
n
tr
o
l 
v
e
lo
c
it
y
 
α-syn PFFs(-) α-syn PFFs(+) 
Ywhae 
Nbr1 
Lamp2 
Rab5b 
Atg12 
Becn1 
Atg3 
Csnk2a1 
Ctsd 
Map1lc3a 
Sqstm1 
Aplp1 
Atg5 
Rab5a 
Nrxn1 
Plk2 
Atg7 
Mtor 
Keap1 
Rab7b 
Nfe2l2 
Lag3 
Rab7a 
Sumo1 
Lamp1 
Rab5c 
K 
α-syn 
PFFs(-) 
α-syn 
PFFs(+) 
Olig2 
Plp1 
Nkx2-2 
Mag 
Cspg4 
Cd200 
Tppp 
Mog 
Mobp 
Gfap 
Pdgfra 
Sox10 
Olig1 
Cnp 
Mbp 
α-syn 
PFFs(-) 
α-syn 
PFFs(+) 
Park7 
Uchl1 
Fbxo7 
Vps35 
Pink1 
Eif4g1 
Gba2 
Gba 
Coq2 
Pla2g6 
Atp13a2 
Snca 
Lrrk2 
Figure S3 Autophagic Response and Functional Influence Induced by α-Syn PFFs Application 
to OPCs 
(A) Immunoblot analysis of OPCs after 24-hour incubation with chloroquine (10 µM) or rapamycin 
(500 nM). Chloroquine induced increased expressions of endogenous rat α-syn, p-62, Beclin-1, 
and LC3-II, while rapamycin induced suppression of these protein expressions. 
(B) (C) Quantification of (B) the endogenous rat α-syn expression and (C) the LC3-II / LC3-I ratio 
is displayed. Mean±SEM; n=4, respectively; independent cultures; one-way ANOVA. *p<0.05, 
***p<0.001. 
(D) Immunoblot analysis of α-syn PFFs-treated OPCs labeled with antibodies against autophagic 
markers, p62, Beclin-1, and LC3, shows the interaction of α-syn with these autophagic markers 
(as indicated by white arrowheads). Each scale bar represents 10 µm. 
(E) Lysosomal localization of α-syn is revealed by LysoTracker (as indicated by white arrowheads) 
24 hours after α-syn PFFs application to OPCs. The scale bar represents 10 µm. 
(F) The alteration of cathepsin D activity in OPCs 24 hours after α-syn PFFs application is shown. 
Each enzymatic activity is indicated by the initial reaction velocity (% of control velocity), 
which was calculated from the change of relative fluorescence units (RFU) during the first 5 
minutes of the reaction. Mean±SEM; n=5, respectively; independent cultures; one-way ANOVA. 
**p<0.01, ***p<0.001. 
(G) (H) LDH as well as WST activity in culture medium indicates that α-syn PFFs application does 
not induce acute cell death in OPCs or OLGs during a time frame of 24 hours. Mean±SEM; n=5, 
respectively; independent cultures. 
(I) (J) Quantitative real-time PCR analysis shows mRNA expression of Gdnf and Igf-1 in α-syn 
PFFs (3 µM)-treated oligodendrocyte lineage cells. Mean±SEM; n=6, respectively; independent 
cultures; paired t-test, *p<0.05. 
(K) (L) (M) RNA-seq analysis of α-syn PFFs-treated OPCs reveals altered expression of transcripts 
related to (K) proteolysis and protein trafficking, (L) phenotypic markers, and (M) risk genes for 
familial Parkinson’s disease and MSA. Each pair of OPC culture samples (OPC1, OPC2, and 
OPC3) was allocated for the two groups with and without α-syn PFFs (3 µM) application. 
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Figure S4 Decreased Expression of Myelin-associated Proteins in OLGs Derived from α-Syn 
PFFs-treated OPCs 
(A) Immunoelectron microscopy of mature OLGs differentiated from α-syn PFFs (1 μM)-pretreated 
OPCs shows intracellular localization of fibrillary α-syn. The primary antibody recognizes both 
rat and human α-syn. a),b) Immunogold labeling of α-syn in OLGs shows intracellular α-syn 
localization (arrow heads). The scale bar represents a) 2 µm and b) 500 nm, respectively. The 
cell membrane is traced with dotted lines. c) Magnified image of gold particles associated with 
fibril-like structures adjacent to the nucleus. The scale bar represents 100 nm. 
(B) (C) α-Syn aggregates in OLGs derived from α-syn PFFs-treated OPCs are vaguely 
immunoreactive to phosphorylated α-syn antibody (B). The scale bar represents 20 µm. The 
expression of phosphorylated α-syn is, however, not clearly confirmed by immunoblot analysis 
(C). 
(D) Quantification by immunoblot analysis in OLGs derived from α-syn PFFs-treated OPCs shows 
significant reductions of MBP and TPPP/p25α protein expression. Mean±SEM; n=4, 
respectively; independent cultures; one-way ANOVA, *p<0.05. 
(E) Confocal microscopy reveals that MBP expression in OLGs containing α-syn aggregates is 
markedly decreased (white arrow heads) in contrast to OLGs not containing aggregates (void 
arrow heads). The scale bar represents 20 µm. TPPP/p25α expression is also affected by α-syn 
PFFs application. Each scale bar represents 20 µm. 
(F) Distribution of cells labeled with PDGFRα and MBP is shown. OLG culture derived from α-syn 
PFFs (1 μM)-treated OPCs contains more PDGFRα-positive cells, compared with normal OLG 
culture. Each scale bar represents 50 µm. 
(G) Quantification of the percentage of PDGFRα-positive cells suggests the inhibition of OLG 
maturation due to α-Syn PFFs (1 μM) application. Mean±SEM; n=3, respectively; independent 
cultures; paired t-test, *p<0.05. 
(H) Quantification of immunoblot analysis of OLG culture derived from α-syn PFFs-treated OPCs 
shows increasing trend of PDGFRα protein expression (normalized by β-actin expression). 
Mean±SEM; n=4, respectively; independent cultures; paired t-test. 
(I) Quantification of Mbp mRNA expression in these OLGs reveals downward trend of Mbp gene 
expression induced by α-syn PFFs (3 μM) application. Mean±SEM; n=4, respectively; 
independent cultures; paired t-test. 
 
  
Supplemental Movie S1 Time-Lapse Video of Primary OPC Culture Incubated with 
Proliferation Medium 
Primary OPC culture was incubated for 62 hours with proliferation medium containing PDGF-AA 
and FGF-2. Images were acquired at defined positions every 10 minutes. 
  
Supplemental Movie S2 Time-Lapse Video of Primary OPC Culture Incubated with 
Differentiation Medium 
Primary OPC culture was incubated for 62 hours with differentiation medium containing CNTF and 
T3. Images were acquired at defined positions every 10 minutes. 
